ARCHIVES

Myriad In Partnership To Market Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

October 31, 2014

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show

November 28, 1986

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

Clinical Trials Approved By NCI CTEP Last Month

December 31, 2010